Pricing Log in Create free account

Artelo Biosciences, Inc. (ARTL) vs Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)

Artelo Biosciences, Inc. and Biodexa Pharmaceuticals PLC Unsponsored ADR are both Biotechnology companies. Artelo Biosciences, Inc. and Biodexa Pharmaceuticals PLC Unsponsored ADR are of similar size ($1.3M and $1.2M). Artelo Biosciences, Inc. has the higher net margin (0.00% vs −1,155.7%) and the lower return on invested capital (−865.9% vs 0.00%). Across the 10 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 7 and Artelo Biosciences, Inc. on 3.

Valuation

Metric ARTL BDRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.12 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.33 0.20 0.66
EV/Sales n/m (2.81) 9.02
Earnings yield (10,336.94%) (102.95%) (32.88%)
Free cash flow yield (2,139.52%) 0.00% (23.13%)

Profitability

Metric ARTL BDRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (1,155.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (705.71%) 0.00% (51.96%)
Return on assets (234.30%) 0.00% (46.06%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL BDRX Biotechnology median
Revenue growth (TTM) — 60.22% 6.76%
EPS growth (last fiscal year) 31.57% 89.62% 29.88%
Revenue growth, 5-year CAGR — (28.78%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL BDRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.00 2.41 4.97
Net debt to EBITDA 0.05 1.00 1.01

Dividend

Metric ARTL BDRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARTL BDRX Biotechnology median
Market cap 1.16m 1.25m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack